Product Information

LYRICA 150 MG CAPSULE is a brand product labeled by Viatris Specialty LLC, priced at $9.6988 per EA under NDC 58151024077. Its NADAC has been published 72 times since Feb 12, 2025.

The High Outlier badge above means this manufacturer's average price in the PREGABALIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LYRICA 150 MG CAPSULE

PREGABALIN
$9.6988per EA
High Outlier
DEA Schedule CV

Strength

150 mg/1

NDC

58151024077

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

PREGABALIN

Approval Type

New Drug (NDA)

FDA Application

NDA021446

On Market Since

11/12/2024

Price Statistics

The NADAC for LYRICA 150 MG CAPSULE has been published 72 times since Feb 12, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$9.6988 per EA
All-time high$9.7044 (Nov 12, 2025)
All-time low$9.6855 (Feb 12, 2025)
52-week high$9.7044
52-week low$9.6934
Median price$9.6996
Average price$9.6976
Largest weekly change+0.1% (Mar 18, 2026)
Weeks tracked72
Tracking sinceFeb 12, 2025

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

-0.0%

1Y

-0.0%

3Y

N/A

5Y

N/A

All

+0.1%

Generic Alternatives

The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LYRICA 150 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LYRICA 150 MG CAPSULE, manufactured by Viatris Specialty LLC, is $9.6988 per EA (NDC 58151024077), effective Jun 24, 2026.

How has the price of LYRICA 150 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LYRICA 150 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 72 weekly CMS publications since Feb 12, 2025.

What are the highest and lowest recorded NADAC prices for LYRICA 150 MG CAPSULE?

Since Feb 12, 2025, the NADAC for LYRICA 150 MG CAPSULE has ranged from a low of $9.6855 (Feb 12, 2025) to a high of $9.7044 (Nov 12, 2025), with a median of $9.6996 per EA.

Are there cheaper alternatives to LYRICA 150 MG CAPSULE?

Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PREGABALIN 150 MG CAPSULE, is $0.0505 per EA — about 99% below LYRICA 150 MG CAPSULE.

Who manufactures LYRICA 150 MG CAPSULE?

LYRICA 150 MG CAPSULE (NDC 58151024077) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.